
In this episode of the Methusalem Podcast, I discuss with Niklas Anzinger, founder and CEO of Infinita City, the story behind Próspera, a special economic zone on the island of Roatán, Honduras. Niklas shares his journey from public policy and the Berlin startup scene to building a jurisdiction designed to accelerate biotech and longevity innovation.
We cover how Próspera operates as a startup city with its own regulatory framework, why Niklas believes FDA-style regulatory monopolies are the biggest bottleneck in longevity research rather than the science itself, and how Próspera's insurance-based regulatory model offers a market-driven alternative. We also discuss biotech companies already operating on-site.
If you're a founder or researcher interested in launching a biotech company in this unique regulatory environment, check out the BioHub Startup Accelerator at luma.com/BioHub2026.
For more information on Infinita City and everything happening at Prospera, visit the homepage at infinita.city.
Mais episódios de "Methusalem Podcast"



Não percas um episódio de “Methusalem Podcast” e subscrevê-lo na aplicação GetPodcast.




